+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Testing Market by Product Type, Technology, Sample Type, Target Molecule, Degree of Automation, Clinical Purpose, Application, End User - Global Forecast 2026-2032- Product Image
Nucleic Acid Testing Market by Product Type, Technology, Sample Type, Target Molecule, Degree of Automation, Clinical Purpose, Application, End User - Global Forecast 2026-2032- Product Image
Sale

Nucleic Acid Testing Market by Product Type, Technology, Sample Type, Target Molecule, Degree of Automation, Clinical Purpose, Application, End User - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968571
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nucleic Acid Testing Market is projected to reach USD 11.33 Billion in 2026. It is expected to continue growing at a CAGR of 9.50%, reaching USD 19.77 Billion by 2032.

Nucleic acid testing, or NAT, is the molecular diagnostics category that detects DNA or RNA from pathogens, inherited conditions, oncology biomarkers, donor blood samples, and other clinically relevant targets. The field includes polymerase chain reaction, reverse transcription PCR, transcription-mediated amplification, loop-mediated isothermal amplification, next-generation sequencing, and digital PCR. Its value proposition is speed, analytical sensitivity, specificity, and the ability to detect infection before serology becomes positive.

Demand remains structurally supported by infectious disease surveillance, blood screening, transplant safety, oncology companion diagnostics, reproductive health, antimicrobial resistance monitoring, and decentralized testing. Public health agencies including WHO, CDC, FDA, ECDC, Africa CDC, and national reference laboratories continue to position molecular testing as a core tool for outbreak detection, treatment decisions, and population-level disease control.

Transformative Shifts in the NAT Landscape

The nucleic acid testing landscape is shifting from centralized, high-complexity laboratories toward a hybrid model that combines reference-lab scale with point-of-care and near-patient access. COVID-19 accelerated installed instrument bases, sample-to-answer workflows, multiplex respiratory panels, laboratory automation, and buyer expectations for faster turnaround times and supply-chain resilience.

A second shift is the move from single-analyte assays to syndromic, quantitative, and sequencing-enabled diagnostics. Hospitals and public health laboratories increasingly require tests that distinguish pathogens with overlapping symptoms, quantify viral load, and identify resistance markers. Regulatory scrutiny is also increasing, particularly for laboratory-developed tests and decentralized platforms, making analytical validation, clinical evidence, cybersecurity, and quality management central competitive differentiators.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence nucleic acid testing across assay design, laboratory operations, result interpretation, and epidemiologic intelligence. Machine learning can accelerate primer and probe selection, evaluate sequence conservation, flag emerging variants, and reduce the risk of assay dropout when pathogens mutate. In sequencing workflows, AI-supported bioinformatics improves variant calling, contamination detection, and clinically relevant classification.

The cumulative impact is operational as well as clinical. AI-enabled demand planning can help laboratories manage reagents and staffing, while automated signal interpretation can support digital PCR and high-throughput platforms. Industry leaders should treat AI as a validated decision-support layer, not a substitute for quality systems, clinical governance, and regulatory-grade evidence.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

Asia-Pacific is a high-priority region for nucleic acid testing because of large patient populations, expanding hospital networks, tuberculosis burden, hepatitis screening, and government investment in domestic diagnostics. China, India, Japan, South Korea, and Australia anchor demand through public health programs, oncology testing, reproductive health, blood safety, and growing use of sequencing in clinical and academic settings.

North America remains the most mature commercialization environment, led by the United States and Canada, where FDA oversight, CLIA laboratories, broad hospital adoption, and reimbursement pathways shape innovation. Europe benefits from strong public health infrastructure, ECDC coordination, IVDR implementation, and established molecular diagnostics adoption across Germany, France, Italy, Spain, and the United Kingdom.

Latin America is expanding NAT access through infectious disease testing, blood safety, and private laboratory networks, with Brazil and Mexico serving as major demand centers. The Middle East is investing in precision medicine, transplant safety, and hospital modernization, especially in GCC markets. Africa is advancing molecular capacity through HIV viral load, tuberculosis, Ebola, mpox, and malaria surveillance, supported by Africa CDC, WHO programs, and donor-backed laboratory networks.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is supported by dengue, tuberculosis, hepatitis, HIV, influenza, and hospital-acquired infection surveillance, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines investing in laboratory modernization at different speeds. The GCC is characterized by high healthcare spending, imported technology adoption, and national genomics and precision medicine programs that create opportunities for automated NAT systems.

The European Union is defined by harmonized regulatory transition under the In Vitro Diagnostic Regulation, cross-border disease surveillance, and strong reference-laboratory capacity. BRICS economies combine scale with local manufacturing ambitions; China and India are particularly important for cost-optimized platforms and high-volume infectious disease testing. G7 markets influence global standards through regulatory science, reimbursement policy, and innovation funding, while NATO countries increasingly view molecular diagnostics as part of biosecurity, preparedness, and resilient medical supply chains.

Key Country Insights Across Major NAT Markets

The United States leads NAT innovation through FDA-cleared and authorized assays, CLIA-certified laboratory networks, hospital molecular testing, and strong biomedical funding. Canada emphasizes public healthcare procurement, respiratory virus surveillance, and oncology diagnostics, while Mexico and Brazil are expanding molecular capacity through public-private laboratory networks, blood safety, and infectious disease programs.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced clinical laboratories with national health systems that prioritize evidence, cost-effectiveness, and regulatory compliance. Russia maintains domestic testing capacity for infectious disease and public health use. China is scaling local molecular platforms, oncology genomics, and infectious disease surveillance; India is expanding affordability-focused molecular access for tuberculosis, viral hepatitis, and reproductive health. Japan, South Korea, and Australia are mature, quality-driven markets with strong demand for automated, multiplex, and sequencing-based NAT solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize assays and platforms that address high-burden clinical needs, deliver measurable workflow efficiency, and comply with evolving regulatory expectations. The most defensible strategies combine validated clinical performance, scalable manufacturing, stable reagent supply, cybersecurity, interoperability with laboratory information systems, and clear health-economic evidence.

Organizations should also localize market access strategies. In mature markets, differentiation depends on automation, multiplexing, turnaround time, reimbursement support, and evidence generation. In emerging markets, success requires affordability, service uptime, training, sample logistics, and partnerships with public health agencies. AI, sequencing, and point-of-care NAT should be adopted with rigorous validation, transparent performance metrics, and post-market monitoring.

Research Methodology

This executive summary is built from a secondary research methodology using publicly available, authoritative sources and cross-validated industry indicators. Core reference points include WHO disease surveillance, CDC testing guidance, FDA diagnostics policy, ECDC public health reporting, IVDR regulatory information, Africa CDC priorities, national health agencies, peer-reviewed literature, and established laboratory medicine standards.

The analysis prioritizes verified trends over speculative estimates. Insights were synthesized across clinical use cases, technology platforms, regional healthcare infrastructure, regulatory frameworks, procurement behavior, and public health demand drivers. Market interpretation focuses on structural forces affecting nucleic acid testing adoption rather than unverified revenue projections.

Conclusion

Nucleic acid testing has moved from a specialized molecular tool to a foundational component of modern healthcare, public health preparedness, blood safety, oncology, and precision medicine. Its continued relevance is supported by the need for earlier detection, faster therapeutic decisions, antimicrobial resistance monitoring, and real-time surveillance of emerging pathogens.

The next phase of competition will be shaped by automation, multiplex panels, sequencing integration, AI-supported analytics, and decentralized access. Organizations that combine analytical accuracy with operational reliability, regulatory discipline, and market-specific affordability will be well positioned to advance in the global NAT ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nucleic Acid Testing Market, by Product Type
7.1. Instruments
7.2. Reagents & Kits
7.3. Software & Services
8. Nucleic Acid Testing Market, by Technology
8.1. Digital PCR
8.2. Isothermal Amplification
8.3. Microarray
8.4. Next Generation Sequencing
8.5. Real Time PCR
9. Nucleic Acid Testing Market, by Sample Type
9.1. Blood
9.2. Saliva
9.3. Swabs
9.4. Tissue
9.5. Urine
10. Nucleic Acid Testing Market, by Target Molecule
10.1. DNA
10.2. RNA
10.3. Combined DNA/RNA
11. Nucleic Acid Testing Market, by Degree Of Automation
11.1. Manual
11.2. Semi-Automated
11.3. Fully Automated
12. Nucleic Acid Testing Market, by Clinical Purpose
12.1. Screening
12.2. Confirmatory Testing
12.3. Monitoring
12.4. Treatment Selection
13. Nucleic Acid Testing Market, by Application
13.1. Clinical Diagnostics
13.2. Drug Discovery
13.3. Forensics
13.4. Research
13.5. Veterinary Diagnostics
14. Nucleic Acid Testing Market, by End User
14.1. Academic Research Institutes
14.2. Diagnostic Laboratories
14.3. Hospitals & Clinics
14.4. Pharmaceutical & Biotechnology Companies
15. Asia-Pacific Nucleic Acid Testing Market
16. North America Nucleic Acid Testing Market
17. Latin America Nucleic Acid Testing Market
18. Europe Nucleic Acid Testing Market
19. Middle East Nucleic Acid Testing Market
20. Africa Nucleic Acid Testing Market
21. ASEAN Nucleic Acid Testing Market
22. GCC Nucleic Acid Testing Market
23. European Union Nucleic Acid Testing Market
24. BRICS Nucleic Acid Testing Market
25. G7 Nucleic Acid Testing Market
26. NATO Nucleic Acid Testing Market
27. United States Nucleic Acid Testing Market
28. Canada Nucleic Acid Testing Market
29. Mexico Nucleic Acid Testing Market
30. Brazil Nucleic Acid Testing Market
31. United Kingdom Nucleic Acid Testing Market
32. Germany Nucleic Acid Testing Market
33. France Nucleic Acid Testing Market
34. Russia Nucleic Acid Testing Market
35. Italy Nucleic Acid Testing Market
36. Spain Nucleic Acid Testing Market
37. China Nucleic Acid Testing Market
38. India Nucleic Acid Testing Market
39. Japan Nucleic Acid Testing Market
40. Australia Nucleic Acid Testing Market
41. South Korea Nucleic Acid Testing Market
42. Competitive Landscape
42.1. Market Concentration Analysis, 2025
42.1.1. Concentration Ratio (CR)
42.1.2. Herfindahl Hirschman Index (HHI)
42.2. Recent Developments & Impact Analysis, 2025
42.3. Product Portfolio Analysis, 2025
42.4. Benchmarking Analysis, 2025
43. Company Profiles
43.1. Abbott Laboratories
43.2. Agilent Technologies, Inc.
43.3. Becton, Dickinson and Company
43.4. BGI Genomics Co., Ltd.
43.5. Bio-Rad Laboratories, Inc.
43.6. bioMérieux SA
43.7. Danaher Corporation
43.8. DiaSorin S.p.A.
43.9. Exact Sciences Corporation
43.10. F. Hoffmann-La Roche Ltd
43.11. Grifols, S.A.
43.12. Hologic, Inc.
43.13. Illumina, Inc.
43.14. Meridian Bioscience, Inc.
43.15. Molbio Diagnostics Private Limited
43.16. Mylab Discovery Solutions Pvt. Ltd.
43.17. Natera, Inc.
43.18. Oxford Nanopore Technologies plc
43.19. Pacific Biosciences of California, Inc.
43.20. Promega Corporation
43.21. QIAGEN N.V.
43.22. Quest Diagnostics Incorporated
43.23. QuidelOrtho Corporation
43.24. Revvity, Inc.
43.25. Sansure Biotech Inc.
43.26. Seegene Inc.
43.27. Siemens Healthineers AG
43.28. Sonic Healthcare Limited
43.29. Sysmex Corporation
43.30. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL NUCLEIC ACID TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NUCLEIC ACID TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2025 VS 2032 (%)
FIGURE 25. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 27. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 29. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 39. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 41. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. G7 NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 51. G7 NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 52. NATO NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 53. NATO NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 54. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. CANADA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. MEXICO NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. GERMANY NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. FRANCE NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. ITALY NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. SPAIN NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 65. INDIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 66. JAPAN NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 67. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 68. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NUCLEIC ACID TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL REAL TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL REAL TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL REAL TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SWABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SWABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SWABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COMBINED DNA/RNA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COMBINED DNA/RNA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COMBINED DNA/RNA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CONFIRMATORY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CONFIRMATORY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CONFIRMATORY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TREATMENT SELECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TREATMENT SELECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TREATMENT SELECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FORENSICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FORENSICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FORENSICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VETERINARY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 161. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 162. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 163. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 170. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 171. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 172. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. GCC NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GCC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. GCC NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 179. GCC NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 180. GCC NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 181. GCC NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 182. GCC NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. GCC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 197. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 198. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 199. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 200. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. G7 NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. G7 NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. G7 NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 206. G7 NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 207. G7 NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 208. G7 NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 209. G7 NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. G7 NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. NATO NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 212. NATO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. NATO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. NATO NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 215. NATO NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 216. NATO NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 217. NATO NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 218. NATO NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. NATO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. CANADA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 234. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 235. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 236. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. MEXICO NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 242. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 243. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 244. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 245. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 252. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 253. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 254. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. GERMANY NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 266. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 267. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 269. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 270. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 271. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 272. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. FRANCE NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 278. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 279. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 280. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 281. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 282. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 287. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 288. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 289. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 290. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 291. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. ITALY NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 294. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 295. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 296. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 297. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 298. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 299. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 301. SPAIN NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 303. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 304. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 305. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 306. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 307. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 308. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 309. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 310. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 311. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 312. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 313. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 314. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 315. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 316. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 317. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 319. INDIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 321. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 322. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 323. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 324. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 325. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 326. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 327. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 328. JAPAN NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 330. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 331. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 332. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 333. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 334. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 335. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 336. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 337. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 338. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 339. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 340. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 341. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 342. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 343. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 344. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 345. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 346. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 347. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 348. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 349. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 350. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TARGET MOLECULE, 2018-2032 (USD MILLION)
TABLE 351. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY DEGREE OF AUTOMATION, 2018-2032 (USD MILLION)
TABLE 352. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL PURPOSE, 2018-2032 (USD MILLION)
TABLE 353. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 354. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Nucleic Acid Testing market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Hologic, Inc.
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Molbio Diagnostics Private Limited
  • Mylab Discovery Solutions Pvt. Ltd.
  • Natera, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Sansure Biotech Inc.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.77 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2026-2034 - Product Image

Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2026-2034

  • Report
  • 142 Pages
  • Global
From
Nucleic Acid Testing - Global Strategic Business Report - Product Image

Nucleic Acid Testing - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
2025 Czechia Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks - Product Image

2025 Czechia Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks

  • Report
  • 1120 Pages
  • Global
From
2025 Global Nucleic Acid Testing (NAT) Market Opportunities in the US, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks - Product Image

2025 Global Nucleic Acid Testing (NAT) Market Opportunities in the US, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks

  • Report
  • 1170 Pages
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
2025 Global Forecast for Trichomonas Vaginalis Nucleic Acid Test Kit Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Trichomonas Vaginalis Nucleic Acid Test Kit Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the NAT Screening Market

The NAT Screening market within the context of In Vitro Diagnostics is a segment of the healthcare industry that focuses on the development and commercialization of tests that detect the presence of infectious agents in a sample. These tests are used to diagnose and monitor the spread of infectious diseases, such as HIV, hepatitis, and other viruses. NAT Screening tests are used in a variety of settings, including clinical laboratories, hospitals, and public health departments. NAT Screening tests are typically performed using a variety of technologies, such as polymerase chain reaction (PCR), nucleic acid hybridization, and enzyme-linked immunosorbent assays (ELISA). These tests are used to detect the presence of specific genetic material in a sample, which can be used to identify the presence of a particular infectious agent. Some companies in the NAT Screening market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.